Intravenous GM
Advocates of biotechnology often cite the case of GM (genetically modified) insulin to demonstrate the safety of GM products. They say that GM insulin has been used for many years and has never caused any problem. But evidence continues to emerge that this is not the case. To cite just one example, the Australian South Gippsland Sentinel Times carried a story in September about the terrible side effects suffered by a diabetic who had unknowingly been using GM insulin for over 20 years. His symptoms included extreme tiredness, weight gain, memory loss, mental confusion, fluctuations in the level of sugar in his blood, constant tiredness, and pain in his joints. Moreover he lost the symptoms associated with hypoglycaemia, which makes the condition dangerous and even life-threatening. He also developed Crohn’s disease – a serious complaint that causes inflammation of the intestine and can cause arthritis, eye inflammations and skin eruptions.
Once he discovered that he was using GM insulin, the patient decided to return to natural insulin obtained from animals. He says that the fluctuations in his sugar level ended immediately and he was able to reduce the amount of insulin in his daily injections by 15 per cent. Many of his other symptoms also improved markedly over time. In the fortnight following publication several readers wrote in about similar side effects caused by GM insulin.
Indeed, diabetes sufferers in other parts of the world have for some time been calling for more rigorous investigations into the safety of GM insulin, also known as human insulin. According to the UK-based Insulin Dependent Diabetes Trust, “The first research in 1980 using GM ‘human’ insulin, by Professor Harry Keen, involved 17 healthy non-diabetic men, and in 1982 ‘human’ insulin was given a licence for general use. This is a remarkably short time for a new drug, especially as ‘human’ insulin was the first ever genetically engineered drug to be used on people.” The Trust’s website (http://www.iddtinternational.org/gmvsanimalinsulin/) contains numerous cases of side effects similar to those reported in Australia.OURCE: http://www.grain.org/seedling/?id=585
Twelve years of GM soya in Argentina - a disaster for people and the environment
GRAIN
Genetically modified (GM) soya was introduced into Argentina in 1996 without any kind of debate either in Congress or among the public. Since then, its cultivation has spread across the country like wildfire. Today more than half of the country’s arable land is planted with soya. No other country in the world has devoted such a large area to a single GM crop. Argentina provides a unique opportunity to investigate the consequences for a country of intensive GMO cultivation.
With this year’s planting season well under way, it is estimated that Argentina will be planting soya on a record 18 million hectares, about half of the country’s farming land. Almost all of the soya planted today is Monsanto’s Roundup Ready (RR), a type of soya that has been genetically modified to be resistant to the Roundup herbicide – largely composed of glyphosate – which is also manufactured by Monsanto. So what have the consequences been for the people and for the country?
Perhaps those who have suffered most have been small farmers and peasant families. Even before RR soya was introduced, the Argentine government adopted policies that favoured big farmers, deciding that farming units smaller than 200 hectares were “uneconomical”, and predicting that at least 200,000 farmers would have to leave the land. [1] Since then, government policies have not changed. Thousands of peasant families have been evicted violently from their land for trying to resist the advance of soya. Members of the Movimiento Campesino de Santiago del Estero (Mocase), a peasant movement in northern Argentina linked to Via Campesina, and of the Movimiento Nacional Campesino Indígena suffer constant harassment for trying to halt the advance of the soya front.
Argentina soybean production
(click on image for larger size)
The families that manage to stay on the land have also been badly affected, particularly by chemical contamination, which has grown worse in recent years. When it introduced RR soya, Monsanto promised that there would be a dramatic decline in herbicide use. As RR soya had been genetically modified to be resistant to glyphosate, Monsanto argued that it would be possible to kill all weeds by applying the herbicide just once, early on in the planting season. In fact, this advantage never materialised as strongly as the company predicted. Instead of falling, national consumption of glyphosate has risen dramatically: Argentina is estimated to have used 200 million litres of glyphosate in 2008, compared with 13.9 million litres in 1996. [2] In other words, while the Argentine soya harvest has increased fivefold during the period, consumption of glyphosate has increased fourteenfold.
The intense application year after year of a single herbicide – glyphosate – has led to the emergence of weeds that have become resistant to this chemical. Some of the better known of these “super-weeds”, as they are popularly called, are: Hybanthus parviflorus (Violetilla), Parietaria debilis (Yerba Fresca), Viola arvensis (Violeta Silvestre – Field pansy), Petunia axillaris (Petunia), Verbena litoralis (Verbena), Commelina erecta (Flor de Santa Lucía – Slender dayflower), Convolvulus arvensis (Correhuela – Field bindweed), Ipomoea purpurea (Bejuco – Morning glory), Iresine difusa (Iresine) and recently Sorghum halepense (Sorgo de alepo – Johnson grass), which, because it is a difficult weed to control, has caused considerable alarm among farmers.
Etiquetas: Argentina, Biotech, Glyphosate, GRAIN, Insulin, Soy
0 Comentarios:
Publicar un comentario
Suscribirse a Comentarios de la entrada [Atom]
<< Página Principal